Literature DB >> 30485837

The Long Noncoding RNA 150Rik Promotes Mesangial Cell Proliferation via miR-451/IGF1R/p38 MAPK Signaling in Diabetic Nephropathy.

Yajuan Zhang1,2, Yan Sun1, Rui Peng3, Handeng Liu1, Weihao He4, Luyu Zhang1, Huimin Peng1, Zheng Zhang5.   

Abstract

BACKGROUND/AIMS: Diabetic nephropathy (DN) as the primary cause of end-stage kidney disease is a common complication of diabetes. However, the initiating molecular events triggering DN are unknown. Recently, long noncoding RNAs (lncRNAs) have been shown to play important roles in DN.
METHODS: The expression level of lncRNA 1500026H17Rik (150Rik for short) was measured by qRT-PCR (quantitative real-time PCR). Cell proliferation ability was detected by 5-Ethynyl-2'-deoxyuridine (EdU). The relationship between 150Rik and microRNA 451 (miR-451) was examined by luciferase assay and RNA immunoprecipitation (RIP) assay. Finally, the effect of 150Rik on cell proliferation through the miR-451/insulin-like growth factor 1 receptor (IGF1R)/mitogen-activated protein kinases (p38MAPK) pathway was detected by EdU, flow cytometry analysis, western blot.
RESULTS: We found that 150Rik, an evolutionarily conserved lncRNA, was significantly upregulated in renal tissue of db/db DN mice and in mesangial cells (MCs) cultured under a high glucose condition. Further, overexpression or knockdown of 150Rik was found to regulate cell proliferation in MCs. Moreover, 150Rik was found to interact with miR-451 in both a direct and argonaute-2 (Ago2)-dependent manner. Results also revealed that overexpression of 150Rik inhibited cell proliferation through the miR-451/IGF1R/p38MAPK pathway in MCs under the high glucose condition, while knockdown of 150Rik increased cell proliferation via the miR-451/IGF1R/p38MAPK pathway.
CONCLUSION: Taken together, these results provide new insight into the association between 150Rik and the miR-451/IGF1R/p38MAPK signaling pathway during DN progression.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Cell proliferation; Diabetic nephropathy; lncRNA; miR-451

Mesh:

Substances:

Year:  2018        PMID: 30485837     DOI: 10.1159/000495590

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  7 in total

1.  Long non-cording RNA XIST promoted cell proliferation and suppressed apoptosis by miR-423-5p/HMGA2 axis in diabetic nephropathy.

Authors:  Hui Chen; Yuan Guo; Xingbo Cheng
Journal:  Mol Cell Biochem       Date:  2021-09-16       Impact factor: 3.396

Review 2.  MicroRNAs in kidney injury and disease.

Authors:  Nassim Mahtal; Olivia Lenoir; Claire Tinel; Dany Anglicheau; Pierre-Louis Tharaux
Journal:  Nat Rev Nephrol       Date:  2022-08-16       Impact factor: 42.439

3.  High glucose promotes annulus fibrosus cell apoptosis through activating the JNK and p38 MAPK pathways.

Authors:  Lizhen Shan; Di Yang; Danjie Zhu; Fabo Feng; Xiaolin Li
Journal:  Biosci Rep       Date:  2019-07-08       Impact factor: 3.840

4.  Knockdown of lncRNA PVT1 alleviates high glucose-induced proliferation and fibrosis in human mesangial cells by miR-23b-3p/WT1 axis.

Authors:  Wen Zhong; Jiaoe Zeng; Junli Xue; Aimin Du; Yancheng Xu
Journal:  Diabetol Metab Syndr       Date:  2020-04-15       Impact factor: 3.320

5.  Weighted Gene Coexpression Network Analysis Identified MicroRNA Coexpression Modules and Related Pathways in Type 2 Diabetes Mellitus.

Authors:  Tianyu Feng; Kexin Li; Pingping Zheng; Yanjun Wang; Yaogai Lv; Li Shen; Yang Chen; Zhiqiang Xue; Bo Li; Lina Jin; Yan Yao
Journal:  Oxid Med Cell Longev       Date:  2019-12-13       Impact factor: 6.543

6.  Exosomal hsa_circ_0125310 promotes cell proliferation and fibrosis in diabetic nephropathy via sponging miR-422a and targeting the IGF1R/p38 axis.

Authors:  Yingchun Zhu; Fangfang Zha; Bo Tang; Ting-Ting Ji; Xiao-Ying Li; Linhong Feng; Shou-Jun Bai
Journal:  J Cell Mol Med       Date:  2021-12-02       Impact factor: 5.310

7.  Loss of lncRNA MIAT ameliorates proliferation and fibrosis of diabetic nephropathy through reducing E2F3 expression.

Authors:  Ting-Ting Ji; Ying-Hui Qi; Xiao-Ying Li; Bo Tang; Ya-Kun Wang; Peng-Xi Zheng; Weiliang Li; Xiaolei Qu; Linhong Feng; Shou-Jun Bai
Journal:  J Cell Mol Med       Date:  2020-10-03       Impact factor: 5.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.